41-2
41st Parliament,
2nd Session
(October 16, 2013 - August 2, 2015)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Hugh MacLeod, Chief Executive Officer(Canadian Patient Safety Institute)
- Emily Musing, Board member(Canadian Patient Safety Institute)
- Dr. Ingrid Sketris, Councillor(Health Council of Canada)
Meeting with interpretation and transcription